Stock 5G3 TALKMED GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News TalkMed Group Limited

Equities

5G3

SG2G61000003

Delayed Singapore S.E.
Other stock markets
 21:18:59 2024-04-28 EDT 		5-day change 1st Jan Change
0.405 SGD -2.41% Intraday chart for TalkMed Group Limited -3.57% +6.58%
04-17 TalkMed Reaches Final Settlement in Mediation Related to Claims in Stem Med Stake Disposal MT
03-14 TalkMed Group Awards 1.1 Million New Shares MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
TalkMed Group Limited Approves Final One-Tier Tax-Exempt Dividend for the Financial Year Ended 31 December 2023
CI
TalkMed Reaches Final Settlement in Mediation Related to Claims in Stem Med Stake Disposal
MT
TalkMed Group Awards 1.1 Million New Shares
MT
TalkMed's H2 Attributable Profit Falls on Wider Impairment Loss
MT
Talkmed Group Limited Proposes Tax Exempt (One-Tier) Final Dividend for the Financial Year Ended 31 December 2023, Payable on 10 May 2024
CI
TalkMed Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023
CI
TalkMed Group Grants Nearly 8 Million Share Awards Under Performance Share Plan
MT
TalkMed Group Limited Announces Management Changes
CI
TalkMed Group Limited Announces Re-Designation of Leong Ching Ching from Non-Executive Director to Independent Non-Executive Director and Appoints as Chairman of the Remuneration Committee, Effective January 1, 2024
CI
TalkMed Group Limited Announces Re-Designation of S. Chandra Das from Independent Non-Executive Director to Non-Independent Non-Executive Director, Effective 1 January 2024
CI
TalkMed Group Limited Announces Re-Designation of Sitoh Yih Pin from Independent Non-Executive Director to Non-Independent Non-Executive Director, Effective 1 January 2024
CI
Talkmed Group Limited Appoints Khoo Kei Siong as Alternate Director to Ang Peng Tiam, Effective January 1, 2024
CI
TalkMed Group Limited Appoints Dr Tan Khai Tong as Independent Non-Executive Director, Member of the Remuneration Committee, Effective January 1, 2024
CI
TalkMed Group Limited Appoints Peter Sim Swee Yam as Independent Non-Executive Director, Chairman of the Nominating Committee, Member of the Audit and Risk Committee, Effective January 1, 2024
CI
TalkMed Group Limited Appoints Lam Kok Shang as Independent Non-Executive Director, Chairman of the Audit and Risk Committee, Member of the Nominating Committee, Effective January 1, 2024
CI
TalkMed Group Issues New Shares Upon Vesting of Share Awards
MT
TalkMed Group Issues New Shares Upon Vesting of Share Awards
MT
Singapore Stocks Track Global Gains to Close Higher; Delfi Shares Jump 3% on Higher H1 Profit, Revenue
MT
TalkMed Group's Attributable Profit Zooms 18% in H1
MT
TalkMed Group Limited Declares Tax Exempt (One-Tier) Interim Dividend for the Financial Year Ending 31 December 2023, Payable on 22 August 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 5G3 Stock
  4. News TalkMed Group Limited